rAAV-Mediated Human FGF-2 Gene Therapy Enhances Osteochondral Repair in a Clinically Relevant Large Animal Model Over Time In Vivo

Background: Osteochondral defects, if left untreated, do not heal and can potentially progress toward osteoarthritis. Direct gene transfer of basic fibroblast growth factor 2 (FGF-2) with the clinically adapted recombinant adeno-associated viral (rAAV) vectors is a powerful tool to durably activate osteochondral repair processes. Purpose: To examine the ability of an rAAV-FGF-2 construct to target the healing processes of focal osteochondral injury over time in a large translational model in vivo versus a control gene transfer condition. Study Design: Controlled laboratory study. Methods: Standardized osteochondral defects created in the knee joints of adult sheep were treated with an rAAV human FGF-2 (hFGF-2) vector by direct administration into the defect relative to control (reporter) rAAV-lacZ gene transfer. Osteochondral repair was monitored using macroscopic, histological, immunohistological, and biochemical methods and by micro–computed tomography after 6 months. Results: Effective, localized prolonged FGF-2 overexpression was achieved for 6 months in vivo relative to the control condition without undesirable leakage of the vectors outside the defects. Such rAAV-mediated hFGF-2 overexpression significantly increased the individual histological parameter “percentage of new subchondral bone” versus lacZ treatment, reflected in a volume of mineralized bone per unit volume of the subchondral bone plate that was equal to a normal osteochondral unit. Also, rAAV-FGF-2 significantly improved the individual histological parameters “defect filling,”“matrix staining,” and “cellular morphology” and the overall cartilage repair score versus the lacZ treatment and led to significantly higher cell densities and significantly higher type II collagen deposition versus lacZ treatment. Likewise, rAAV-FGF-2 significantly decreased type I collagen expression within the cartilaginous repair tissue. Conclusion: The current work shows the potential of direct rAAV-mediated FGF-2 gene therapy to enhance osteochondral repair in a large, clinically relevant animal model over time in vivo. Clinical Relevance: Delivery of therapeutic (hFGF-2) rAAV vectors in sites of focal injury may offer novel, convenient tools to enhance osteochondral repair in the near future.

[1]  H. Madry,et al.  Small-Diameter Subchondral Drilling Improves DNA and Proteoglycan Content of the Cartilaginous Repair Tissue in a Large Animal Model of a Full-Thickness Chondral Defect , 2020, Journal of clinical medicine.

[2]  K. Shea,et al.  Autologous Chondrocyte Implantation as Treatment for Unsalvageable Osteochondritis Dissecans: 10- to 25-Year Follow-up , 2020, The American journal of sports medicine.

[3]  Fumiko Yano,et al.  Multi-layered PLLA-nanosheets loaded with FGF-2 induce robust bone regeneration with controlled release in critical-sized mouse femoral defects. , 2019, Acta biomaterialia.

[4]  H. Madry,et al.  Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair , 2018, Nature Reviews Rheumatology.

[5]  D. Zurakowski,et al.  Effects of TGF-β Overexpression via rAAV Gene Transfer on the Early Repair Processes in an Osteochondral Defect Model in Minipigs , 2018, The American journal of sports medicine.

[6]  D. Zurakowski,et al.  Sustained spatiotemporal release of TGF‐β1 confers enhanced very early chondrogenic differentiation during osteochondral repair in specific topographic patterns , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  Wenyu Yang,et al.  Targeted delivery of FGF2 to subchondral bone enhanced the repair of articular cartilage defect. , 2018, Acta biomaterialia.

[8]  M. Stuart,et al.  High Rate of Osteoarthritis After Osteochondritis Dissecans Fragment Excision Compared With Surgical Restoration at a Mean 16-Year Follow-up , 2017, The American journal of sports medicine.

[9]  M. Nevitt,et al.  Brief Report: Partial‐ and Full‐Thickness Focal Cartilage Defects Contribute Equally to Development of New Cartilage Damage in Knee Osteoarthritis: The Multicenter Osteoarthritis Study , 2016, Arthritis & rheumatology.

[10]  M. Cucchiarini.  Human gene therapy: novel approaches to improve the current gene delivery systems. , 2016, Discovery medicine.

[11]  A. Rey-Rico,et al.  Co-overexpression of TGF-β and SOX9 via rAAV gene transfer modulates the metabolic and chondrogenic activities of human bone marrow-derived mesenchymal stem cells , 2016, Stem Cell Research & Therapy.

[12]  D. Zurakowski,et al.  Small-Diameter Awls Improve Articular Cartilage Repair After Microfracture Treatment in a Translational Animal Model , 2016, The American journal of sports medicine.

[13]  H. Madry,et al.  Large animal models in experimental knee sports surgery: focus on clinical translation , 2015, Journal of Experimental Orthopaedics.

[14]  Johnny Huard,et al.  Gene therapy approaches to regenerating the musculoskeletal system , 2015, Nature Reviews Rheumatology.

[15]  J. Welter,et al.  Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation. , 2015, Osteoarthritis and cartilage.

[16]  H. Madry,et al.  Small Subchondral Drill Holes Improve Marrow Stimulation of Articular Cartilage Defects , 2014, The American journal of sports medicine.

[17]  H. Madry,et al.  Overexpression of human IGF-I via direct rAAV-mediated gene transfer improves the early repair of articular cartilage defects in vivo , 2014, Gene Therapy.

[18]  Arnold I Caplan,et al.  Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations. , 2014, Tissue engineering. Part B, Reviews.

[19]  H. Madry,et al.  Improved repair of chondral and osteochondral defects in the ovine trochlea compared with the medial condyle , 2013, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[20]  J. Wang,et al.  Exogenous bFGF promotes articular cartilage repair via up-regulation of multiple growth factors. , 2013, Osteoarthritis and cartilage.

[21]  D. Zurakowski,et al.  Reduction of sample size requirements by bilateral versus unilateral research designs in animal models for cartilage tissue engineering. , 2013, Tissue engineering. Part C, Methods.

[22]  D. Zurakowski,et al.  Parathyroid hormone [1-34] improves articular cartilage surface architecture and integration and subchondral bone reconstitution in osteochondral defects in vivo. , 2013, Osteoarthritis and cartilage.

[23]  H. Madry,et al.  A low morbidity surgical approach to the sheep femoral trochlea , 2013, BMC Musculoskeletal Disorders.

[24]  H. Madry,et al.  Direct rAAV SOX9 administration for durable articular cartilage repair with delayed terminal differentiation and hypertrophy in vivo , 2012, Journal of Molecular Medicine.

[25]  N. Weber,et al.  Fibroblast growth factor 2 enhances the kinetics of mesenchymal stem cell chondrogenesis. , 2012, Biochemical and biophysical research communications.

[26]  A. Bücker,et al.  Experimental scoring systems for macroscopic articular cartilage repair correlate with the MOCART score assessed by a high-field MRI at 9.4 T--comparative evaluation of five macroscopic scoring systems in a large animal cartilage defect model. , 2012, Osteoarthritis and cartilage.

[27]  D. Zurakowski,et al.  Reliability, reproducibility, and validation of five major histological scoring systems for experimental articular cartilage repair in the rabbit model. , 2012, Tissue engineering. Part C, Methods.

[28]  R. Cancedda,et al.  The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model. , 2012, Biomaterials.

[29]  H. Kim,et al.  Collagen three-dimensional hydrogel matrix carrying basic fibroblast growth factor for the cultivation of mesenchymal stem cells and osteogenic differentiation. , 2012, Tissue engineering. Part A.

[30]  U. Wolfram,et al.  Effect of Subchondral Drilling on the Microarchitecture of Subchondral Bone , 2012, The American journal of sports medicine.

[31]  Kiyofumi Takabatake,et al.  Basic fibroblast growth factor supports expansion of mouse compact bone-derived mesenchymal stem cells (MSCs) and regeneration of bone from MSC in vivo , 2011, Journal of Molecular Histology.

[32]  M. Knopp,et al.  Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model. , 2011, Osteoarthritis and cartilage.

[33]  Magali Cucchiarini,et al.  Metabolic activities and chondrogenic differentiation of human mesenchymal stem cells following recombinant adeno-associated virus-mediated gene transfer and overexpression of fibroblast growth factor 2. , 2011, Tissue engineering. Part A.

[34]  H. Madry,et al.  Gene Therapy for Cartilage Repair , 2011, Cartilage.

[35]  Masanori Kikuchi,et al.  Repair of large osteochondral defects in rabbits using porous hydroxyapatite/collagen (HAp/Col) and fibroblast growth factor‐2 (FGF‐2) , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[36]  M. Szczodry,et al.  Animal models for cartilage regeneration and repair. , 2010, Tissue engineering. Part B, Reviews.

[37]  Antonios G Mikos,et al.  Repair of osteochondral defects with biodegradable hydrogel composites encapsulating marrow mesenchymal stem cells in a rabbit model. , 2010, Acta biomaterialia.

[38]  W. Widuchowski,et al.  Isolated full thickness chondral injuries. Prevalance and outcome of treatment. A retrospective study of 5233 knee arthroscopies. , 2008, Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca.

[39]  Paul D Robbins,et al.  IL-1ra/IGF-1 Gene Therapy Modulates Repair of Microfractured Chondral Defects , 2007, Clinical orthopaedics and related research.

[40]  Xin Huang,et al.  Osteochondral repair using the combination of fibroblast growth factor and amorphous calcium phosphate/poly(L-lactic acid) hybrid materials. , 2007, Biomaterials.

[41]  D. Zurakowski,et al.  Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF‐2) in vivo , 2006, The journal of gene medicine.

[42]  H. Mizukami,et al.  Repair of articular cartilage defect by intraarticular administration of basic fibroblast growth factor gene, using adeno-associated virus vector. , 2005, Human gene therapy.

[43]  H. Madry,et al.  Gene therapy for cartilage defects , 2005, The journal of gene medicine.

[44]  D. Zurakowski,et al.  Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[45]  Hitoshi Hirata,et al.  Enhanced repair of large osteochondral defects using a combination of artificial cartilage and basic fibroblast growth factor. , 2005, Biomaterials.

[46]  V. Goldberg,et al.  FGF‐2 enhances the mitotic and chondrogenic potentials of human adult bone marrow‐derived mesenchymal stem cells , 2005, Journal of cellular physiology.

[47]  H. Mizukami,et al.  Repair of articular cartilage defect by autologous transplantation of basic fibroblast growth factor gene-transduced chondrocytes with adeno-associated virus vector. , 2005, Arthritis and rheumatism.

[48]  K. Takagi,et al.  One day exposure to FGF-2 was sufficient for the regenerative repair of full-thickness defects of articular cartilage in rabbits. , 2004, Osteoarthritis and cartilage.

[49]  K. Yonenobu,et al.  Fibroblast growth factor-2 promotes the repair of partial thickness defects of articular cartilage in immature rabbits but not in mature rabbits. , 2004, Osteoarthritis and cartilage.

[50]  Hiroshi Tanaka,et al.  Effects of basic fibroblast growth factor on the repair of large osteochondral defects of articular cartilage in rabbits: dose-response effects and long-term outcomes. , 2004, Tissue engineering.

[51]  K. Takagi,et al.  Active proliferation of mesenchymal cells prior to the chondrogenic repair response in rabbit full-thickness defects of articular cartilage. , 2004, Osteoarthritis and cartilage.

[52]  D. Zurakowski,et al.  Overexpression of human fibroblast growth factor 2 stimulates cell proliferation in an ex vivo model of articular chondrocyte transplantation , 2004, The journal of gene medicine.

[53]  K. Iyama,et al.  Differentiation of chondrogenic precursor cells during the regeneration of articular cartilage. , 2001, Osteoarthritis and cartilage.

[54]  S. B. Adams,et al.  The surgical anatomy of the stifle joint in sheep. , 1998, Veterinary surgery : VS.

[55]  E. Morris,et al.  The Effect of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) on the Healing of Full-Thickness Defects of Articular Cartilage* , 1997, The Journal of bone and joint surgery. American volume.

[56]  B. P. Smith,et al.  Cartilage injuries: a review of 31,516 knee arthroscopies. , 1997, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

[57]  E. Hunziker,et al.  Repair of Partial-Thickness Defects in Articular Cartilage: Cell Recruitment from the Synovial Membrane* , 1996, The Journal of bone and joint surgery. American volume.

[58]  T. Flotte,et al.  Adeno-associated virus vectors for gene therapy. , 1995, Gene therapy.

[59]  P. Robbins,et al.  Possible orthopaedic applications of gene therapy. , 1995, The Journal of bone and joint surgery. American volume.

[60]  S. Trippel.  Growth factor actions on articular cartilage. , 1995, The Journal of rheumatology. Supplement.

[61]  M J Glimcher,et al.  Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. , 1993, The Journal of bone and joint surgery. American volume.

[62]  Samulski,et al.  Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression , 1989, Journal of virology.

[63]  H. Mankin,et al.  Growth factor stimulation of adult articular cartilage , 1989, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[64]  R. Samulski,et al.  A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication , 1987, Journal of virology.